Barriers to Adoption

FEATUREBattling Bad BehaviorBarriers to AdoptionHow can we improve the pace at which best practices are implemented? BY MICHAEL D. CABANA ARTICLE EXTRASRelated Articles: Battling Bad BehaviorHow do you convince people to do what's in their best interest? College Drinking: Norms vs. Perceptions Through medical history, improved practices are often accepted at a glacial pace. The British N

Written byMichael D. Cabana
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

How can we improve the pace at which best practices are implemented?

Through medical history, improved practices are often accepted at a glacial pace. The British Navy adopted citrus fruit to prevent scurvy in 1795, almost 50 years after James Lind's observations were initially circulated. More than two centuries later, barriers to implement better practices still remain. But in this information age, awareness is only part of the problem, and the entire medical community from publishers, to practitioners, to consumers must work to improve adoption.

Pediatric asthma affects close to 5 million children in the United States. In 1997 the National Institutes of Health published practice guidelines to "bridge the gap between current knowledge and practice." Based on numerous studies, the NIH guidelines recommend that physicians prescribe daily-inhaled corticosteroids for children with persistent asthma symptoms.

The guidelines have had limited impact. A national survey found that only 55% of patients ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies